BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/26/2022 7:50:06 AM | Browse: 164 | Download: 323
 |
Received |
|
2021-09-14 08:36 |
|
Peer-Review Started |
|
2021-09-14 08:38 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-12-27 02:55 |
|
Revised |
|
2022-01-05 01:21 |
|
Second Decision |
|
2022-07-15 03:27 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2022-07-18 21:23 |
|
Articles in Press |
|
2022-07-18 21:23 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2022-07-09 01:28 |
|
Typeset the Manuscript |
|
2022-08-18 09:33 |
|
Publish the Manuscript Online |
|
2022-08-26 07:50 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
Wumei pills attenuates 5-fluorouracil-induced intestinal mucositis through Toll-like receptor 4/myeloid differentiation factor 88/nuclear factor-κB pathway and microbiota regulation
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Dong-Xue Lu, Feng Liu, Hua Wu, Hai-Xia Liu, Bing-Yu Chen, Jing Yan, Yin Lu and Zhi-Guang Sun |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
81673795 |
|
| Corresponding Author |
Zhi-Guang Sun, PhD, Chief Doctor, Professor, The First Clinical Medical College, Nanjing University of Chinese Medicine, No. 138, Xianlin Avenue, Qixia District, Nanjing 210023, Jiangsu Province, China. 110399@njucm.edu.cn |
| Key Words |
Wumei pills; Gut flora; Intestinal mucosal inflammation; Mucosal barrier; Short-chain fatty acids; Intestinal permeability |
| Core Tip |
In this study, the compound Wumei pills was selected as the representative of the traditional Chinese medicine compound, and it was clarified that the compatibility of the compound medicines may also regulate the intestinal flora, which is instructive for the study of the onset mode and mechanism of the Chinese medicine compound. The results obtained will provide a scientific basis for finding clinical potential treatment and intervention strategies for chemotherapy-induced intestinal mucositis. |
| Publish Date |
2022-08-26 07:50 |
| Citation |
Lu DX, Liu F, Wu H, Liu HX, Chen BY, Yan J, Lu Y, Sun ZG. Wumei pills attenuates 5-fluorouracil-induced intestinal mucositis through Toll-like receptor 4/myeloid differentiation factor 88/nuclear factor-κB pathway and microbiota regulation. World J Gastroenterol 2022; 28(32): 4574-4599 |
| URL |
https://www.wjgnet.com/1007-9327/full/v28/i32/4574.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v28.i32.4574 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
